Intuitive Surgical Trounces Analysts' Q2 Estimates
Healthcare company Intuitive Surgical (NASDAQ: ISRG) has been somewhat pushed aside as investors in the sector focus their interest on companies working to fight the coronavirus pandemic. However, after the market closed on Tuesday, the robotic surgical systems maker reported second-quarter results that well-exceeded analysts' consensus estimates -- which might make its stock harder to keep ignoring.
For the quarter, revenue fell by 22% on a year-over-year basis to just over $852 million. Non-GAAP (adjusted) net income dropped more precipitously, declining by 66% to slightly more than $132 million, or $1.11 per share.
Image source: Intuitive Surgical.
Source Fool.com
